myirislogo
24 October, 2019 01:53 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Infosys 650.75 1.16
Tata Motors 132.65 0.57
Tata Power 60.80 2.62
Adani Ports 396.25 5.85
State Bank O 275.50 1.87
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Claris Lifesciences Limited
Claris Lifesciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:33288NSE:NABloomberg:CLAR@INReuters:CLAI.BO
Market Lot: 1Face Value: 10ISIN Demat: INE562G01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
01-JUN-17 Claris Lifesciences (CLL) along with its wholly owned subsidiary Claris Injectables (CIL) has underwent a successful USFDA Pharmacovigilance (PV) audit from May 29 to May 31 with No Observation (i483s). 08-MAY-17 Claris Lifesciences has received an approval for the sale and transfer of the equity shares of Otsuka Pharmaceutical India (formerly knowns as Claris Otsuka) to Otsuka Pharmaceutical Factory, Inc for a consideration of USD 2...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Claris Lifesciences gets nod to sell stake in JV to Otsuka  -IRIS 08-May-17
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2016(6)31-Dec-2015(12)31-Dec-2014(12)
Net sales 1387.205531.525925.71
Other Income248.63512.18680.74
Total Income1635.836043.706606.45
Cost of goods sold1503.005765.214824.56
OPBDIT132.83278.491781.89
PAT71.87-57.701414.68
Gross Block---
Equity capital545.68545.68545.68
EPS (Rs.)---
DPS (Rs.)---
BV (Rs.)---
P/E range (x)---
Debt / Equity (x)---
Operating margin (% of OI) 8.1 4.627.0
Net margin (% of OI) 4.4-1.021.4
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Claris Corporate Headquarters
Near Parimal Railway Crossing
Ellisbridge
Ahmedabad
Gujarat-380 006
PHONE
(079) 2656 3331/ 6630 9330
FAX
(079) 2656 5879/ 2640 8053
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer